FDA is seeking feedback on a discussion paper weighing the benefits and risks of autonomous and remote-controlled robotic ...

Divyesh Sharma is a Senior Healthcare Writer at Ailoitte & writes about medical software regulatory pathways and the influence on engineering.

Hyperfine's Q3 revenue topped cash burn for the first time, marking a major step toward capital efficiency and profitability.

Senseonics' Q3 2026 revenue grew 140% YoY, driving raised full-year guidance and a 30%+ stock surge to a 52-week high.

AAHKS warns Medicare's 2027 cuts to hip and knee replacement payments threaten procedure volumes, tech adoption, and medtech ...

Forget Congress — the real medtech question for 2027 is whether hospital customers can still afford capital equipment ...

Draeger, BD, Edwards, Philips, Cardinal Health, Medline, and Nova Biomedical issued major recalls in October 2026 after ...

FDA denied Novocure's PMA for Optune Mya, citing a lack of clinical benefit evidence, though no safety concerns were raised.

Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...

The softer sales, along with reimbursement pressure in wound care, caused the London-based company to miss Wall Street ...

Simtra's Mike Schaefer on how the GLP-1 boom is reshaping CDMO strategy, from regional manufacturing to cold-chain capacity.

Check out these 10 editorial nominees for the 2026 Medtech Company of the Year, then vote for your choice at the end of the list.